These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1490653)

  • 1. Twenty-four-hour serum growth hormone, insulin, C-peptide and blood glucose profiles and serum insulin-like growth factor-I concentrations in women with polycystic ovaries.
    Prelević GM; Wurzburger MI; Balint-Perić L; Ginsburg J
    Horm Res; 1992; 37(4-5):125-31. PubMed ID: 1490653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An abnormality of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovary syndrome due to coexistent obesity.
    Slowinska-Srzednicka J; Zgliczynski W; Makowska A; Jeske W; Brzezinska A; Soszynski P; Zgliczynski S
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1432-5. PubMed ID: 1534330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overnight secretion pattern of growth hormone, sex hormone binding globulin, insulin-like growth factor-1 and its binding protein in obese and non-obese women with polycystic ovarian disease.
    Insler V; Barash A; Shoham Z; Koistinen R; Seppala M; Hen M; Lunenfeld B; Zadik Z
    Isr J Med Sci; 1994 Jan; 30(1):42-7. PubMed ID: 7511134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between hormonal and metabolic profiles in women with polycystic ovary syndrome].
    Esposito V; Federico P; Lo Iudice G; Rispoli C; Sabatino P; D'Alessandro B
    Minerva Endocrinol; 1992; 17(1):21-9. PubMed ID: 1495451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystic ovaries in non-obese and obese patients: possible pathophysiological mechanism based on new interpretation of facts and findings.
    Insler V; Shoham Z; Barash A; Koistinen R; Seppälä M; Hen M; Lunenfeld B; Zadik Z
    Hum Reprod; 1993 Mar; 8(3):379-84. PubMed ID: 7682564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute cholinergic blockade with low dose pirenzepine reduces the insulin and glucose responses to a mixed meal in obese women with the polycystic ovary syndrome.
    Premawardhana LD; Ismail IS; Riad-Fahmy D; Miell JP; Peters JR; Scanlon MF
    Clin Endocrinol (Oxf); 1994 May; 40(5):617-21. PubMed ID: 7516827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycystic ovary syndrome: obesity, insulin resistance, hyperandrogenism.
    Lo Dico G; Alongi G; Savatteri L; Rini GB; Mascellino MR; Di Fede G; Rizzo G
    Acta Eur Fertil; 1989; 20(5):309-13. PubMed ID: 2700062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone and somatomedin-C secretion in patients with polycystic ovarian disease. Their relationships with hyperinsulinism and hyperandrogenism.
    Lanzone A; Fulghesu AM; Pappalardo S; Proto C; Le Donne M; Andreani CL; Muscatello R; Caruso A; Mancuso S
    Gynecol Obstet Invest; 1990; 29(2):149-53. PubMed ID: 2110544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects.
    Rasmussen MH; Hvidberg A; Juul A; Main KM; Gotfredsen A; Skakkebaek NE; Hilsted J; Skakkebae NE
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1407-15. PubMed ID: 7536210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia.
    Dunaif A; Graf M; Mandeli J; Laumas V; Dobrjansky A
    J Clin Endocrinol Metab; 1987 Sep; 65(3):499-507. PubMed ID: 3305551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma androgens and oestradiol during oral glucose tolerance test in patients with polycystic ovaries.
    Tiitinen A; Pekonen F; Stenman UH; Laatikainen T
    Hum Reprod; 1990 Apr; 5(3):242-5. PubMed ID: 2191000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The independent effects of hyperandrogenaemia, hyperinsulinaemia, and obesity on lipid and lipoprotein profiles in women.
    Graf MJ; Richards CJ; Brown V; Meissner L; Dunaif A
    Clin Endocrinol (Oxf); 1990 Jul; 33(1):119-31. PubMed ID: 2205423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.
    Apter D; Bützow T; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2966-73. PubMed ID: 7559882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Insulin resistance and serum concentrations of ovarian and adrenal androgen in obese women without additional disease and with policystic ovary syndrome].
    Olszanecka-Glinianowicz M; Banaś M; Zahorska-Markiewicz B; Kuglin D; Mokrzycka J; Mentel A
    Endokrynol Pol; 2005; 56(6):921-6. PubMed ID: 16821212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome.
    Holte J; Bergh T; Berne C; Wide L; Lithell H
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2586-93. PubMed ID: 7673399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of obesity on ovarian function. I. Serum insulin and insulin dependent protein concentrations in obese patients with polycystic ovary syndrome].
    Kinalski M; Kowalska I; Wołczyński S; Straczkowski M; Telejko B; Kinalska I; Szamatowicz M
    Ginekol Pol; 1999 Jun; 70(6):419-26. PubMed ID: 10895282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An abnormality of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovary syndrome.
    Kazer RR; Unterman TG; Glick RP
    J Clin Endocrinol Metab; 1990 Oct; 71(4):958-62. PubMed ID: 2401719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance in patients with polycystic ovaries: its relationship to body weight and androgen levels.
    Pasquali R; Casimirri F; Venturoli S; Paradisi R; Mattioli L; Capelli M; Melchionda N; Labò G
    Acta Endocrinol (Copenh); 1983 Sep; 104(1):110-6. PubMed ID: 6137924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diet-induced changes in sex hormone binding globulin and free testosterone in women with normal or polycystic ovaries: correlation with serum insulin and insulin-like growth factor-I.
    Kiddy DS; Hamilton-Fairley D; Seppälä M; Koistinen R; James VH; Reed MJ; Franks S
    Clin Endocrinol (Oxf); 1989 Dec; 31(6):757-63. PubMed ID: 2697481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.